# Prochlorperazine

## Novamin inj 5mg/1mL

| TAH Drug Code      | [**INOV**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INOV)                                                                                                                                                                                                                                                                                           |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of nausea and vomiting, Nausea and vomiting,Adjunctive management of severe anxiety disorders ,Psychoses                                                                                                                                                                                                                                                |
| Dosing             | IM Nausea and vomiting As mesilate: 12.5 mg, may repeat via PO if needed. Psychoses As mesilate: 12.5-25 mg, 2-3 times/day. Rectal Nausea and vomiting As 25 mg supp: 1 supp twice daily. Psychoses As maleate: 25 mg 2-3 times/day.                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | CNS depression, comatose patients. Bone marrow depression, phaechromocytoma, prolactin-dependent tumours, hypersensitivity. Childn <2 yr. Pregnancy and lactation.                                                                                                                                                                                                 |
| Adverse Effects    | Cholestatic jaundice, cardiac arrhythmias, orthostatic hypotension, leucopaenia, thrombocytopaenia, dry mouth, blurring of vision, glaucoma, urinary retention, constipation, galactorrhoea, gynaecomastia, amenorrhoea and impotence. Buccal: Transient numbness of gum and tongue. Potentially Fatal: Bone-marrow suppression. Cardiac arrhythmias or aspiration |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                       |

## Novamin 5mg

| TAH Drug Code      | [**ONOV**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONOV)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Pyschosis, nausea, vomiting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Adult: 5-10 mg TID-QID (maximum: 150 mg/day). Children > 2 years or > 9 kg: 0.1 mg/kg or 2.5mg/m2 QID. Antiemetic: Body weight 9-13 kg: 2.5mg QD-BID, maximum: 7.5mg/day. Body weight 14-17 kg: 2.5mg BID-TID, maximum: 10 mg/day. Body weight 18-39 kg: 2.5mg TID or 5mg BID, maximum: 15 mg/day. For antipsychotic or sedation (2-12 years): 2.5mg BID-TID. Note: 1. Not recommended for children under 9 kg. Maximum dosage: first day, 10 mg; thereafter (2-5 years) 20mg/day; (6 to 12 years) 25 mg/day. 2. Children with an acute illness or dehydration are at increased risk of extrapyramidal syndrome. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Bone-marrow depression.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | CV & haematological changes, GI disturbances. Hepatic dysfunction, Malin syndrome, extrapyrimidal reactions, visual disturbances, weight increase, breast enlargement changes in libido, dysmenorrhoea, CNS disorders, photosensitivity.                                                                                                                                                                                                                                                                                                                                                                         |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

